Daniel P. O'Day - Mar 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Stock symbol
GILD
Transactions as of
Mar 10, 2023
Transactions value $
-$1,114,352
Form type
4
Date filed
3/14/2023, 12:03 PM
Previous filing
Mar 2, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +19.5K +5.42% 379K Mar 10, 2023 Direct F1
transaction GILD Common Stock Options Exercise +10.8K +2.85% 390K Mar 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$1.11M -14K -3.6% $79.50 376K Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -19.5K -16.79% 96.6K Mar 10, 2023 Common Stock 19.5K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -10.8K -11.18% 85.8K Mar 10, 2023 Common Stock 10.8K Direct F1, F3
transaction GILD Restricted Stock Unit Award +47.2K +55% 133K Mar 10, 2023 Common Stock 47.2K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +215K $0.00 215K Mar 10, 2023 Common Stock 215K $79.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.